SCHEMBL21048429

SCHEMBL21048429

O=P(O)(O)CSc1nc2cc(C(F)(F)F)ccc2s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.59
DYRK1A Q13627 2/20 0.50
PPARA Q07869 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MEN1 O00255 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.44
GPR55 Q9Y2T6 1/20 0.44
NCS1 P62166 1/20 0.43
AKR1B1 P15121 6/20 0.42
P2RY2 P41231 1/20 0.42
TRPV1 Q8NER1 1/20 0.41
ILK Q13418 2/20 0.40
AGPAT2 O15120 1/20 0.40
AKR1B10 O60218 1/20 0.39
AKR1A1 P14550 1/20 0.39
GLO1 Q04760 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19828210 0.83 ALOX5 (0.53) ALOX5DYRK1APPARAL3MBTL1MEN1
SCHEMBL9393819 0.79 ALOX5 (0.61) ALOX5DYRK1APPARAL3MBTL1MEN1
SCHEMBL9443101 0.79 ALOX5 (0.64) ALOX5DYRK1APPARAL3MBTL1MEN1
SCHEMBL30602944 0.78 SMN1; SMN2 (0.59) ALOX5DYRK1APPARAL3MBTL1CYP1A2
SCHEMBL3660244 0.78 SMN1; SMN2 (0.59) ALOX5DYRK1APPARAL3MBTL1CYP1A2
SCHEMBL10761623 0.77 DYRK1A (0.60) ALOX5DYRK1APPARAL3MBTL1MEN1
SCHEMBL17153983 0.77 ALOX5 (0.52) ALOX5DYRK1APPARAL3MBTL1MEN1
SCHEMBL10358369 0.77 ALOX5 (0.62) ALOX5DYRK1APPARAL3MBTL1MEN1
SCHEMBL3018322 0.76 MAPT (0.64) ALOX5L3MBTL1MEN1CYP1A2CYP3A4
SCHEMBL9186874 0.75 ALOX5 (0.57) ALOX5DYRK1APPARAL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10315990-B2 Isothiocyanate compounds and isothiocyanate XPO1 protein inhibitor drugs thereof DRIVINGFORCE THERAPEUTICS (CN) 2019-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10315990-B2 Isothiocyanate compounds and isothiocyanate XPO1 protein inhibitor drugs thereof XPO1, XPOT, XPO4 ALOX5 4747/4885DYRK1A 3977/4885PPARA 4002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.